These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31798836)

  • 21. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
    Gauthier-Loiselle M; Tsang Y; Lefebvre P; Agron P; Royer J; Bell Lynum KS; Bennett L; Panjabi S
    Curr Med Res Opin; 2022 Jun; 38(6):1019-1030. PubMed ID: 35243952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
    Bauer Y; de Bernard S; Hickey P; Ballard K; Cruz J; Cornelisse P; Chadha-Boreham H; Distler O; Rosenberg D; Doelberg M; Roux S; Nayler O; Lawrie A
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
    Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic- and scleroderma-related pulmonary arterial hypertension: outcomes and QOL on bosentan.
    Keogh A; Wlodarczyk J
    Expert Rev Pharmacoecon Outcomes Res; 2004 Oct; 4(5):505-13. PubMed ID: 19807544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
    Santaniello A; Casella R; Vicenzi M; Rota I; Montanelli G; De Santis M; Bellocchi C; Lombardi F; Beretta L
    Rheumatology (Oxford); 2020 Jul; 59(7):1581-1586. PubMed ID: 31637433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases.
    Sprecher VP; Didden EM; Swerdel JN; Muller A
    Pulm Circ; 2020; 10(4):2045894020961713. PubMed ID: 33240487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
    Tomaszewski M; Małkowska P; Sierawska O; Hrynkiewicz R; Mroczek E; Darocha S; Hymos A; Błaszczak P; Grywalska E; Niedźwiedzka-Rystwej P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Interpretable Longitudinal Preeclampsia Risk Prediction Using Machine Learning.
    Eberhard BW; Cohen RY; Rigoni J; Bates DW; Gray KJ; Kovacheva VP
    medRxiv; 2023 Aug; ():. PubMed ID: 37645797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.
    Thakkar V; Stevens WM; Moore OA; Nikpour M
    Intern Med J; 2013 Jul; 43(7):751-60. PubMed ID: 23611651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.
    Zhang C; Tsang Y; He J; Panjabi S
    Adv Ther; 2023 May; 40(5):2481-2492. PubMed ID: 37024760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population.
    Li L; Jick S; Breitenstein S; Hernandez G; Michel A; Vizcaya D
    Pulm Circ; 2017 Mar; 7(1):126-136. PubMed ID: 28680572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding undiagnosed patients with hepatitis C virus: an application of machine learning to US ambulatory electronic medical records.
    Rigg J; Doyle O; McDonogh N; Leavitt N; Ali R; Son A; Kreter B
    BMJ Health Care Inform; 2023 Jan; 30(1):. PubMed ID: 36639190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center.
    Guillén-Del Castillo A; Callejas-Moraga EL; García G; Rodríguez-Palomares JF; Román A; Berastegui C; López-Meseguer M; Domingo E; Fonollosa-Plá V; Simeón-Aznar CP
    Arthritis Res Ther; 2017 Jun; 19(1):135. PubMed ID: 28615037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.